AU4027097A – Method of treatment
– Google Patents
AU4027097A – Method of treatment
– Google Patents
Method of treatment
Info
Publication number
AU4027097A
AU4027097A
AU40270/97A
AU4027097A
AU4027097A
AU 4027097 A
AU4027097 A
AU 4027097A
AU 40270/97 A
AU40270/97 A
AU 40270/97A
AU 4027097 A
AU4027097 A
AU 4027097A
AU 4027097 A
AU4027097 A
AU 4027097A
Authority
AU
Australia
Prior art keywords
treatment
Prior art date
1996-09-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40270/97A
Inventor
Birgitta Brunes
Christian Brunes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1996-09-03
Filing date
1997-09-01
Publication date
1998-03-26
1997-09-01
Application filed by Scotia Holdings PLC
filed
Critical
Scotia Holdings PLC
1998-03-26
Publication of AU4027097A
publication
Critical
patent/AU4027097A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
A61K31/19—Carboxylic acids, e.g. valproic acid
A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
A61K31/404—Indoles, e.g. pindolol
A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
AU40270/97A
1996-09-03
1997-09-01
Method of treatment
Abandoned
AU4027097A
(en)
Applications Claiming Priority (3)
Application Number
Priority Date
Filing Date
Title
GBGB9618341.3A
GB9618341D0
(en)
1996-09-03
1996-09-03
Method of treatment
GB9618341
1996-09-03
PCT/GB1997/002349
WO1998009623A2
(en)
1996-09-03
1997-09-01
Use of cholinergic drugs
Publications (1)
Publication Number
Publication Date
AU4027097A
true
AU4027097A
(en)
1998-03-26
Family
ID=10799318
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU40270/97A
Abandoned
AU4027097A
(en)
1996-09-03
1997-09-01
Method of treatment
Country Status (4)
Country
Link
AU
(1)
AU4027097A
(en)
GB
(1)
GB9618341D0
(en)
WO
(1)
WO1998009623A2
(en)
ZA
(1)
ZA977867B
(en)
Families Citing this family (6)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
EP1814532B1
(en)
1999-05-27
2012-01-18
George F. El Khoury
Topical application of muscarinic and opioid agents for treatment of tinnitus
GB2355191A
(en)
*
1999-10-12
2001-04-18
Laxdale Ltd
Combination formulations for fatigue, head injury and strokes
EP1190709A1
(en)
*
2000-09-21
2002-03-27
Tinnitus Forschungs- und Entwicklungs GmbH
Treatment of tinnitus
GB0216027D0
(en)
2002-07-10
2002-08-21
Arachnova Therapeutics Ltd
New therapeutic use
WO2011058366A1
(en)
2009-11-12
2011-05-19
Acacia Pharma Limited
Use of bethanechol for treatment of xerostomia
GB201107533D0
(en)
*
2011-05-06
2011-06-22
Acacia Pharma Ltd
Formulaiton
Family Cites Families (4)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4857534A
(en)
*
1984-04-05
1989-08-15
North Carolina State University
Method of maintaining ruminants on high energy low fiber diet
US5668117A
(en)
*
1991-02-22
1997-09-16
Shapiro; Howard K.
Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
WO1994001108A1
(en)
*
1992-07-02
1994-01-20
Theratech, Inc.
Controlled release pilocarpine delivery system
JP2852608B2
(en)
*
1994-06-27
1999-02-03
雪印乳業株式会社
Xerostomia treatment
1996
1996-09-03
GB
GBGB9618341.3A
patent/GB9618341D0/en
active
Pending
1997
1997-09-01
WO
PCT/GB1997/002349
patent/WO1998009623A2/en
active
Application Filing
1997-09-01
AU
AU40270/97A
patent/AU4027097A/en
not_active
Abandoned
1997-09-02
ZA
ZA9707867A
patent/ZA977867B/en
unknown
Also Published As
Publication number
Publication date
GB9618341D0
(en)
1996-10-16
WO1998009623A3
(en)
1998-08-27
ZA977867B
(en)
1998-05-27
WO1998009623A2
(en)
1998-03-12
Similar Documents
Publication
Publication Date
Title
AU6578998A
(en)
1998-10-20
Method of treatment of migraine
AU2543097A
(en)
1997-10-17
Method for treating pain
AU2587297A
(en)
1997-10-17
Method for treating pain
AUPN271295A0
(en)
1995-05-25
Method of treatment
GB9617780D0
(en)
1996-10-02
Method of treatment
AU2972497A
(en)
1998-01-05
Treatment of oils
AU2807297A
(en)
1997-11-12
Methods of treating wastewater
EP0933803A4
(en)
1999-10-20
Method of plasma treatment
AU2340897A
(en)
1997-10-17
Method for treating pain
AU4027097A
(en)
1998-03-26
Method of treatment
AU2051397A
(en)
1997-09-10
Method of treating alopecia
AU1926597A
(en)
1997-10-01
Treatment of cocoa
ZA973988B
(en)
1998-11-09
Method of treatment
AU7113996A
(en)
1997-04-09
Methods of treating beta-amyloid-associated conditions
GB9507825D0
(en)
1995-05-31
Method of treatment
AUPO124196A0
(en)
1996-08-15
Method of ground treatment
AUPO438796A0
(en)
1997-01-23
Method of treatment
AUPN952996A0
(en)
1996-05-23
Method of treatment
AUPN925096A0
(en)
1996-05-09
Methods of treatment
AUPP110197A0
(en)
1998-01-22
Method of treatment
AUPP045397A0
(en)
1997-12-18
Method of treatment
AUPO582097A0
(en)
1997-04-17
Method of treatment
AU1829695A
(en)
1995-08-15
Method of treatment of talc
AUPO269896A0
(en)
1996-10-24
A method of treatment
AUPN762796A0
(en)
1996-02-08
Method of treatment of anorgasmic women
None